Philips' RADIQAL Study to Examine Ultra-Low X-ray Dose Technology in Coronary Procedures

tim.hodson

Tue, 05/27/2025 – 12:26

May 20, 2025 — Royal Philips has launched  the RADIQAL (Radiation Dose and Image Quality Trial) trial. This multicenter, randomized study, sponsored by Philips will enroll 824 coronary artery disease patients across 6 hospitals in Spain, Czech Republic and the US. The first patient in the study was enrolled at Aarhus University Hospital, Denmark.
“The ability to reduce radiation exposure without compromising procedural performance is a key priorit…

Read the full article on itnonline.com